ASDr. Ahmed ShihabConsultant Anesthesiologist – Baghdad عربي

Fundamentals of TCI Pumps and Patient Warming Devices During Anaesthesia

Topic notes · Equipment & Monitoring · Other equipment and safety

A precise understanding of how continuous infusion pumps work and of control of the patient's temperature is one of the mainstays of anaesthetic safety in the operating theatre. This article aims to clarify the fundamental differences between pharmacokinetic drug models, the dangers of mechanical siphoning, the phases of temperature disturbance and ways of warming the patient.

Pharmacokinetic Models for Target-Controlled Infusion (TCI)

The application of TCI for propofol relies on several pharmacokinetic models; the Marsh model depends on total body weight without entering age, and is characterised by a larger central compartment and is generally used in plasma targeting mode. In contrast, the Schnider model enters the variables of age, height, lean body mass and sex, relying on a smaller and fixed central compartment, and is usually used in effect-site targeting. Effect-site targeting also results in a larger initial bolus dose to speed equilibration, causing a transient overshoot of the plasma concentration, compared with plasma targeting, which gives a smaller initial bolus dose.

Syringe Pump Safety and the Free-Flow Phenomenon

Working with syringe pumps requires great caution regarding the phenomenon of siphoning. If the syringe inside the pump is not securely fixed or is cracked, with the device placed at a level higher than the patient, the force of gravity causes free flow of the drug, creating an imminent drug hazard. Adding anti-siphon valves is the decisive mechanical solution to prevent this uncontrolled flow.

The Dynamics of Hypothermia and Forced-Air Warming

Core temperature falls during anaesthesia over three distinct phases: the first phase (phase 1 redistribution), in which temperature falls by about 1°C in approximately the first 30 minutes as a result of redistribution of heat from the core to the periphery, followed by the second phase, which is characterised by a linear loss, then the third phase, which settles at a constant level (plateau) as a result of thermoregulatory vasoconstriction. Forced-air warming devices for the patient rely on convective warming; pre-warming helps to reduce the fall in temperature caused by redistribution. Strict caution must be taken against directing the device's hose straight at the patient without a blanket, to avoid causing thermal tissue burns.

Key points
  • The Marsh model relies on total body weight only, whereas Schnider incorporates the criteria of age, height, lean body mass and sex.
  • Effect-site targeting gives a larger initial dose with a transient overshoot of plasma concentration to speed arrival at the drug target.
  • Anti-siphon valves prevent gravity-driven free flow when the syringe is cracked or not secured.
  • Core temperature falls by about 1°C during the first hour because of redistribution, and plateaus in the third phase because of vasoconstriction.
  • Forced-air warming relies on convective heat transfer, and blowing the hose directly without a blanket is prohibited to avoid burns.

Sources

  • Anaesthesia, Intensive Care and Perioperative Medicine A-Z, 6th ed., pp. 569–570
  • Anaesthesia, Intensive Care and Perioperative Medicine A-Z, 6th ed., p. 570
  • Smith and Aitkenhead's Textbook of Anaesthesia, 8th ed., p. 19
  • Essentials of Equipment in Anaesthesia, 5th ed., p. 224
  • Smith and Aitkenhead's Textbook of Anaesthesia, 7th ed., p. 248
  • The MGH Textbook of Anesthetic Equipment, pp. 264–265

Test yourself: 6 questions on this topic and many more →

Educational content for healthcare staff and students. It does not replace clinical judgement or your hospital protocol; check any dose against the reference and local guidance before use.